8Cao JP, Liu SX. Schistosomiasis vaccine development in China[C]. Asian Parasitology-Vol.5 Schistosomiasis in Asia. 2005. 163-176.
9Liu SX, Song GC, Xu YX, et al. Progress in the development of vaccine against Schistosoma japonicum [J]. Int J Infect Dis,1998, 2: 176-180.
10Pearce EJ. Progress towards a vaccine for schistosomiasis[J].Acta Trop, 2003, 86: 309-313.
二级参考文献118
1[1]Haynes JR, Fuller DH, McCabe D, et al. Induction and characterization of humoral and cellular immune response elicited via gene gun-mediated nucleic acid immunization [J]. Adv Drug Delivery Rev 1996.21:3.
2[2]Wolff JA. Malone RW. Williams P. et al. Direct gene transfer into mouse muscle in viro[J]. Science. 1990,247: 1465.
3[3]Lai WC. Bennett M. DNA vaccines[J]. Crit Rev Immunol. 1998, 18(5) :449.
5[5]Castes M, Blackwell J, Trujillo D, et al. Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG I skin test reactivity T cell proliferation and interferon-gamma production[J]. Vaccine,1994, 12:1041.
6[6]Bahar K, Shidani B, Dowlati Y, et al. Overview of human vaccine studies using killed L. major. In 13th International Congress for Tropical Medicine and Malaria Faculty of Tropical Medicine, Mahidol University, Bangkok, Abstracts. 1993,Vol 1:183.
7[7]Yang DM, Fairweather N, Button L, et al. Oral Salmaonella typhimurium (Aro A) vaccine expressing a major leishmanial surface protein(gp63) preferentially induced Th1 cells and protective immunity against leishmaniasis[J]. J Immunol,1990,145:2281.
8[8]Connell ND, Medina-Acosta E, McMaster RW, et al. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface protein gp63[J]. Proc Natl Acad Sci USA, 1993,90:11473.
